Evidence map›Paper›PMID 17224913›Full record

ReviewThe pharmacogenomics journal2007

Overview of the pharmacogenomics of cigarette smoking.

M K Ho, R F Tyndale

Abstract readReview
PubMed Publisher
In one paragraph

Review in The pharmacogenomics journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 114 citations in OpenAlex.

  1. Trial
  2. Article
  3. Nicotine Effects on White Matter Microstructure in Young Adults.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. GRONS: a comprehensive genetic resource of nicotine and smoking.Database : the journal of biological databases and curation · 2017
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Genetics and smoking.Current addiction reports · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers.American journal of respiratory and critical care medicine · 2013
    Article
  18. Article
  19. Article
  20. Do initial responses to drugs predict future use or abuse?Neuroscience and biobehavioral reviews · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

M K HoCentre for Addiction and Mental Health, Department of Pharmacology, University of Toronto, Toronto, Canada.
R F Tyndale
Centre for Addiction and Mental Health · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cigarette smoking increases the risk of numerous health problems, including cancer, cardiovascular and pulmonary disorders, making smoking the leading cause of preventable death in the world. Nicotine is primarily responsible for the highly addictive properties of cigarettes. Although the majority of smokers express a desire to quit, few are successful in doing so. Twin and family studies have indicated substantial genetic contributions to smoking behaviors. One major research focus has been to elucidate the specific genes involved; this has been accomplished primarily through genome-wide linkage analyses and candidate gene association studies. Much attention has focused on genes involved in the neurotransmitter pathways for the brain reward system and genes altering nicotine metabolism. This paper reviews the current state of knowledge for genetic factors implicated in smoking behaviors, and examines how genetic variations may affect therapeutic outcomes for drugs used to assist smoking cessation.

Indexed as

Polymorphism, Single NucleotideSmoking PreventionAryl Hydrocarbon HydroxylasesBehavior, AddictiveCytochrome P-450 CYP2A6DopamineDopamine Plasma Membrane Transport ProteinsGene Expression Regulation, EnzymologicGenetic LinkageGenetic Predisposition to DiseaseGenotypeHumansMixed Function OxygenasesNicotinePatient SelectionReceptors, CholinergicAryl Hydrocarbon HydroxylasesCytochrome P-450 CYP2A6DopamineDopamine Plasma Membrane Transport ProteinsMixed Function OxygenasesNicotineReceptors, CholinergicReceptors, DopamineSerotoninSerotonin Plasma Membrane Transport ProteinsTryptophan Hydroxylase

Identifiers

PMID17224913
OpenAlexW2122485375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.